SPY314.38-1.80 -0.57%
DIA257.24-3.48 -1.33%
IXIC10,547.75+55.25 0.53%

Morgan Stanley Initiates Coverage On Legend Biotech with Overweight Rating, Announces Price Target of $55

Morgan Stanley initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Overweight rating and announces Price Target of $55.

Benzinga · -
Morgan Stanley initiates coverage on Legend Biotech (NASDAQ: LEGN) with a Overweight rating and announces Price Target of $55.